Portal de Periódicos da CAPES

Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis

2010; Elsevier BV; Volume: 2015; Issue: 4 Linguagem: Inglês

10.1002/14651858.cd008495

1465-1858

Wanruchada Katchamart, Judith Trudeau, Veerapong Phumethum, Claire Bombardier,

Acute Lymphoblastic Leukemia research

Methotrexate (MTX) is among the most effective disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA) with less toxicity and better tolerability.